BRITTANY SPINOSA-WEBER: Open Payments
NPI 1104423193 · SUGARLOAF, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,714 in 194 payments from 22 companies in 2025. Trend: 2023 $3,442 · 2024 $14,644 · 2025 $9,714
Speaker / faculty: $6,450Food & beverage: $3,008Education: $158Travel & lodging: $97
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $6,593 |
| ABBVIE INC. | 32 | $476 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $311 |
| UCB, Inc. | 22 | $309 |
| Galderma Laboratories, L.P. | 19 | $266 |
| Novartis Pharmaceuticals Corporation | 19 | $264 |
| GENZYME CORPORATION | 9 | $220 |
| Regeneron Healthcare Solutions, Inc. | 10 | $211 |
| Organon LLC | 15 | $195 |
| Janssen Biotech, Inc. | 13 | $191 |
Products named: EBGLYSS, DUPIXENT, Bimzelx, SKYRIZI, NEMLUVIO, ILUMYA, COSENTYX, RINVOQ.
Industry payments across PA — which companies pay providers there.
